Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Understanding Conflicts of Interest in Rational Drug Prescription in a Developing Country: A Stakeholder Analysis, Healthcare Guidelines and Ethical Public Health Issues Publisher Pubmed



Moradi F1 ; Bazyar M2 ; Soroush A3 ; Seyedin H4 ; Soleymani F5 ; Etemadi M6, 7 ; Ezadi S8 ; Salimi M9 ; Behzadifar M10 ; Martini M11 ; Hussain R12
Authors
Show Affiliations
Authors Affiliations
  1. 1. Social Development and Health Promotion Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran
  2. 2. Department of Health Management and Economics, Faculty of Health, Ilam University of Medical Sciences, Ilam, Iran
  3. 3. Cardiovascular Research Center, Imam Ali Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran
  4. 4. Department of Health Disaster Management, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran
  5. 5. Department of Pharmaco-economics and Pharmaceutical Management, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
  6. 6. The National Institute for Health and Care Research Applied Research Collaboration West (NIHR ARC West), University Hospitals Bristol, Weston NHS Foundation Trust, United Kingdom
  7. 7. Population Health Sciences, Bristol Medical School, University of Bristol, United Kingdom
  8. 8. Department of Health and Social Medicine, Faculty of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran
  9. 9. Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran
  10. 10. Social Determinants of Health Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran
  11. 11. Department of Health Sciences, University of Genoa, Genoa, Italy
  12. 12. Division of Developmental Biology and Medicine, Maternal and Fetal Health Research Centre, St. Mary’s Hospital, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom

Source: Journal of Preventive Medicine and Hygiene Published:2023


Abstract

Background. Rational drug prescription (RDP) is one of the main rity Organization as one of the main health insurance organizacomponents of the healthcare systems. Irrational prescribing can tions, pharmaceutical companies, and the Medical Council of bring about numerous negative consequences for the patients and the Islamic Republic of Iran, are among agencies that have great governmental agencies. This study aims to analyze the involve-authority to improve rational prescribing, they fail to act profesment of stakeholders in rational drug prescribing, their position sionally as they have conflicting interests. Remarkably, the Iran (opponent or proponent), and the rationale behind it. Food and Drug Administration, insurance organizations, family Methods. This was a qualitative study conducted in 2019. physicians, and patients, highly support the rational prescribing Semi-structured face-to-face interviews were conducted with 40 policy while the pharmaceutical companies display the least sup-stakeholders. Purposive and snowball sampling techniques with port for it. maximum heterogeneity were adopted to select the interview-Conclusions. To make the prescription and using drugs more ees. Data was analyzed by MAXQDA software using thematic rational, policy makers should focus on different sources of con-approach. flicts of interest that different actors have. They should devise Results. Iranian Food and Drug Administration employs the legal, behavior and financial policies accordingly to lessen or at highest authority on the rational prescribing policy. Although least neutralize these conflicting interests, otherwise achieving the Ministry of Health and Medical Education, the Social SecuRDP would be impossible in short and long terms. © Copyright by Pacini Editore Srl, Pisa, Italy.